Rai Neeraj Kumar, Mathur Shashank, Singh Suraj Kumar, Tiwari Meenakshi, Singh Vijay Kumar, Haque Rizwanul, Tiwari Swasti, Kumar Sharma Lokendra
Department of Biotechnology, Central University of South Bihar, Gaya, Bihar 824236, India.
Department of Molecular Medicine and Biotechnology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh 226014, India.
Oncol Lett. 2020 Dec;20(6):313. doi: 10.3892/ol.2020.12176. Epub 2020 Sep 30.
Mitochondria serve a vital role in cellular homeostasis as they regulate cell proliferation and death pathways, which are attributed to mitochondrial bioenergetics, free radicals and metabolism. Alterations in mitochondrial functions have been reported in various diseases, including cancer. Colorectal cancer (CRC) is one of the most common metastatic cancer types with high mortality rates. Although mitochondrial oxidative stress has been associated with CRC, its specific mechanism and contribution to metastatic progression remain poorly understood. Therefore, the aims of the present study were to investigate the role of mitochondria in CRC cells with low and high metastatic potential and to evaluate the contribution of mitochondrial respiratory chain (RC) complexes in oncogenic signaling pathways. The present results demonstrated that cell lines with low metastatic potential were resistant to mitochondrial complex I (C-I)-mediated oxidative stress, and had C-I inhibition with impaired mitochondrial functions. These adaptations enabled cells to cope with higher oxidative stress. Conversely, cells with high metastatic potential demonstrated functional C-I with improved mitochondrial function due to coordinated upregulation of mitochondrial biogenesis and metabolic reprogramming. Pharmacological inhibition of C-I in high metastatic cells resulted in increased sensitivity to cell death and decreased metastatic signaling. The present findings identified the differential regulation of mitochondrial functions in CRC cells, based on CRC metastatic potential. Specifically, it was suggested that a functional C-I is required for high metastatic features of cancer cells, and the role of C-I could be further examined as a potential target in the development of novel therapies for diagnosing high metastatic cancer types.
线粒体在细胞稳态中发挥着至关重要的作用,因为它们调节细胞增殖和死亡途径,这归因于线粒体生物能量学、自由基和代谢。线粒体功能的改变已在包括癌症在内的各种疾病中被报道。结直肠癌(CRC)是最常见的转移性癌症类型之一,死亡率很高。尽管线粒体氧化应激与CRC有关,但其具体机制及其对转移进展的贡献仍知之甚少。因此,本研究的目的是研究线粒体在具有低转移潜能和高转移潜能的CRC细胞中的作用,并评估线粒体呼吸链(RC)复合物在致癌信号通路中的作用。目前的结果表明,具有低转移潜能的细胞系对线粒体复合物I(C-I)介导的氧化应激具有抗性,并且存在C-I抑制以及线粒体功能受损。这些适应性使细胞能够应对更高的氧化应激。相反,具有高转移潜能的细胞表现出功能性C-I,由于线粒体生物发生的协同上调和代谢重编程,线粒体功能得到改善。对高转移细胞中的C-I进行药理抑制导致对细胞死亡的敏感性增加和转移信号减少。本研究结果基于CRC转移潜能确定了CRC细胞中线粒体功能的差异调节。具体而言,提示功能性C-I是癌细胞高转移特征所必需的,并且C-I的作用可作为诊断高转移癌症类型的新疗法开发中的潜在靶点进一步研究。